STALIF M FLX 3D-Printed ALIF Device Listed by SPINE Market Group as the Top ALIF 3D-printed Cage

February 11, 2021

STALIF M FLX platform represents the latest material advancement offered by Centinel Spine.

FLX implants are 3D-printed porous titanium, meticulously engineered down to the cellular unit level to mimic bone. The FLX family of implants boasts equivalent subsidence performance to PEEK; contains a proprietary, interconnected FUSE-THRU lattice with a structure similar to bone; and has an optimized mechanical environment to reduce stress shielding, enable fusion assessment, and support bony in-growth, on-growth, and thru-growth.

STALIF M FLX implants have been engineered based on the STALIF® design which has over 30 years of proven clinical history and has helped thousands of patients regain their lives—including the world’s winningest athlete, Tiger Woods. STALIF implants uniquely provide compressive fixation at the fusion site, pulling the vertebral bodies onto the implant and graft material to enhance opportunities for fusion in line with Wolff’s Law of Bone Healing.

Centinel Spine is proud that the STALIF M FLX device has been recognized as the top ALIF 3D-printed cage,” stated Centinel Spine CEO Steve Murray. “As a company, we remain dedicated to continued product quality, innovation, and furthering clinical evidence. STALIF M FLX is the latest evolution of the STALIF portfolio, and continues our heritage in advancing the stand-alone market founded over 30 years ago,” concluded Murray.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.